Echinacea Symposium Presents New Research On Chernobyl Victims

The results from a long-term clinical study in the Ukraine on the use of Echinacea to treat victims of the Chernobyl disaster is among the new studies to be presented at the 1999 International Echinacea Symposium June 3-5 in Kansas City, MO.

Dr. Victoriya F. Pochernyayeva, a leading researcher from Ukraine and the former Soviet Union, will review the results of her long-term studies including:

  • An analysis of how effectively Echinacea purpurea, consumed as a food additive in fruit juices and other non-alcoholic and alcoholic drinks, protects people who are exposed to radiation. Based on her findings, Dr. Pochernyayeva recommends ways Echinacea purpurea food additives can be used most effectively to safeguard a population that is facing high levels of radiation exposure;
  • A study of how Echinacea purpurea can protect the male reproductive system from the effects of radiation;
  • A study of how effectively Echinacea purpurea can protect organs and tissues from radiation damage.

The world's leading Echinacea researcher, Dr. Rudolf Bauer, is the keynote speaker. Dr. Bauer, professor at the Institute of Pharmaceutical Biology, University of Dusseldorf, has published more than 100 research papers and has edited a book on Echinacea. He's currently researching the quality aspects of Echinacea preparations, constituents and pharmacological activity of Echinacea species.

The event is hosted by the American Herbal Products Association. Sponsors include Nature's Way, Botanicals International, Bioforce USA, Finzelberg North America, Rexall Sundown, Indena USA, and Plantation Medicinals.

Who: Some 150 researchers, scientists and other professionals from the herbal industry.

What: 1999 International Echinacea Symposium

Where: Ritz-Carlton, Kansas City, MO.

When: June 3-5, 1999

Why: To present the latest clinical research, and learn about the

Contact: Brian Ruberry
American Herbal Products Association

Page: 1 2 3

Related biology news :

1. NIH funds botanical center in Iowa to study health effects of Echinacea and St. Johns wort
2. Worlds Leading Echinacea Researchers To Examine Latest Scientific Findings On "Natures Gentle Antibiotic"
3. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
4. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
6. Health of worlds sea lions the focus of Wakefield Symposium
7. Chemical signals health of brain cells Symposium
8. Final Alert: 16th EORTC NCI AACR Symposium
9. 16th EORTC NCI AACR Symposium
10. Symposium to tackle questions of genetic engineering and biodiversity
11. Fostering Diversity in the Sciences Symposium

Post Your Comments:

(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
Cached News: